Old antibiotic is finally synthesized

Nov 27, 2006

The need for new antibiotics to combat multi-drug resistant bacteria has led U.S. chemists to the first synthesis of a potentially valuable antibiotic.

Daniel Kahne and colleagues at Harvard University report the first total synthesis of the antibiotic moenomycin -- a drug that has been sidelined from clinical use for 40 years.

Moenomycin is a broad-spectrum antibiotic with strong antibacterial activity against a large group of bacteria that cause pneumonia, urinary tract infections, gastritis, stomach ulcers, food poisoning and other disorders. Moenomycin also kills bacteria in an unusual way -- it binds directly to enzymes that bacteria need to form a cell wall.

Although used as a growth promoter in animals, moenomycin has never been developed for medical use in humans because it is poorly absorbed into the body. Kahne says discovery of a method to synthesize moenomycin is important because it will allow scientists to better understand the antibiotic and make variants of the natural antibiotic that may be suitable for medical use.

The research appeared in the Nov. 15 issue of the Journal of the American Chemical Society.

Copyright 2006 by United Press International

Explore further: Biologists reprogram skin cells to mimic rare disease

add to favorites email to friend print save as pdf

Related Stories

Premier FBI cybersquad in Pittsburgh to add agents

7 hours ago

The FBI's premier cybersquad has focused attention on computer-based crime in recent months by helping prosecutors charge five Chinese army intelligence officials with stealing trade secrets from major companies and by snaring ...

Recommended for you

Biologists reprogram skin cells to mimic rare disease

4 hours ago

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

Student seeks to improve pneumonia vaccines

Aug 20, 2014

Almost a million Americans fall ill with pneumonia each year. Nearly half of these cases require hospitalization, and 5-7 percent are fatal. Current vaccines provide protection against some strains of the ...

Seabed solution for cold sores

Aug 20, 2014

The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney.

User comments : 0